Literature DB >> 8609439

Stress, stigmatization and psychosomatic purpuras.

E Panconesi1, G Hautmann.   

Abstract

Stress is a term that is readily recognized by everyone but defines rigorous scientific definition. It is widely interpreted as the emotional and biologic responses to novel or threatening situations. In humans, however, the term "distress" seems to be preferable, more clearly defining the fact that is the response that is being referred to, rather than the stimulus. Distress has been postulated to be capable of precipitating an overt illness, as when it occurs coincidentally with an incipient infection or neoplasm. Moreover, it is able to provoke several disorders and symptoms in many tissues and organs, including the skin. In this paper the authors focus on the main characteristics of stress and emphasize the relevance of psychosomatic medicine that proposes the simultaneous examination of psyche and soma. Special consideration is given to a peculiar form of skin disease, psychogenic purpura, together with the stigmata of mystics that, in large part, seem to be conditioned or provoked (or provocable) by emotional stress or by psychic influences on cutaneous fibrinolytic activity.

Entities:  

Mesh:

Year:  1995        PMID: 8609439

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  3 in total

1.  Psychogenic Purpura (Gardner-Diamond Syndrome).

Authors:  Mohammad Jafferany; Gaurav Bhattacharya
Journal:  Prim Care Companion CNS Disord       Date:  2015-01-22

Review 2.  Does dehydroepiandrosterone influence the expression of urticaria?-a mini review.

Authors:  A Kasperska-Zajac
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

3.  Does omalizumab treatment affect serum dehydroepiandrosterone sulphate levels in chronic idiopathic urticaria?

Authors:  Atıl Avcı; Deniz Avcı; Ragip Ertas; Mustafa Atasoy; Cigdem Karakukcu; Efşan Yontar; Yilmaz Ulas; Kemal Ozyurt
Journal:  Postepy Dermatol Alergol       Date:  2019-02-22       Impact factor: 1.837

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.